SCHEMBL31020166

SCHEMBL31020166

CC(O)CC1CCC(C(C)C(=O)O)O1

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.31
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31374768 1.00 ACE (0.31) ACETP53
SCHEMBL24993782 0.87 CTSK (0.30)
SCHEMBL31374769 0.85
SCHEMBL29884873 0.85
SCHEMBL8584966 0.85
SCHEMBL31374767 0.81 TRPA1 (0.34)
SCHEMBL31374766 0.81 TRPA1 (0.34)
SCHEMBL14260761 0.81 ACE (0.30) ACE
SCHEMBL13456280 0.77
Bonactin SCHEMBL30930197 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642420-A1 SKIN TREATMENT USING NO Yes2No GmbH (DE) 2025-11-05 EP disclosed
US-20250332193-A1 SKIN TREATMENT USING NO YES2NO GMBH (DE) 2025-10-30 US disclosed
CN-118903541-A Bioabsorbable bone implant material 常州市第二人民医院 2024-11-08 CN disclosed
WO-2024141643-A1 SKIN TREATMENT USING NO YES2NO GMBH (DE) 2024-07-04 WO disclosed